n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, T; Doughty, L; Guthrie, R; Hattarki, M; Hewish, D; Kortt, AA; Molloy, PL; Ow, K; Russell, PJ; Shapira, D; Sterling-Levis, K; Werkmeister, JA | 1 |
1 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Cancer of Prostate
Article | Year |
---|---|
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Division; Cross-Linking Reagents; Cytotoxicity, Immunologic; Flow Cytometry; Humans; Immunoconjugates; In Vitro Techniques; Male; Melitten; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Peptide Fragments; Prostatic Neoplasms; Succinimides; Survival Rate; Tumor Cells, Cultured | 2004 |